Max Ritvo, Alan Slifka and Desiree Dato Fund for Fusion-Oncoprotein Cancers and Metastasis

קרןIsrael Cancer Research Fund (ICRF)
מדינהU.S.A.
סוגPartnership Activities
תאריך אחרון15/03/2020
פקולטהLife Sciences, Medicine
תיאור

The Max Ritvo, Alan Slifka and Desiree Dato Fund for Fusion-Oncoprotein Cancers and Metastasis, seeks Joint applications form US and Israeli partners addressing at least one of the following topics:

  1. Cancers driven by fusion oncoproteins with Ewing sarcoma as the prototype.
  2. The roles of epigenetic dysfunction or tumor microenvironment in the development of metastatic cancer
 
 
 
 
Funding: $125,000 total per partner
Duration: 2 years
 
 

Only one (1) proposal per institution is allowed.  Pls. submit LOI TO Liat Grumberg until 5.3.20

 
 
Research Authority due date: 5.3.20
LOI (required) due date: 15.3.20
Full proposal due date: 1.6.20
קבצים מצורפים
שיתוף פעולהU.S.A.
קישורלאתר
עדכון אחרוןעדכון אחרון: 09/02/2020
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive